免疫亲和柱净化-超高效液相色谱-三重四极杆质谱法高灵敏测定尿液和血浆中3种鹅膏毒肽

建立了超高效液相色谱-三重四极杆质谱高灵敏测定尿液和血浆中α-鹅膏毒肽、β-鹅膏毒肽和γ-鹅膏毒肽的方法。经过免疫亲和柱净化,尿液样品浓缩20倍、血浆样品浓缩10倍,以Kinetex Biphenyl色谱柱(100 mm×2.1 mm, 1.7 μm)作为分析柱,甲醇-0.005%(v/v)甲酸水溶液作为流动相进行梯度洗脱分离,电喷雾电离、负离子、多反应监测模式下检测,外标法定量。3种鹅膏毒肽的线性范围为0.1~200 ng/mL,相关系数(r)>0.999。尿液和血浆中3种鹅膏毒肽的基质效应和提取回收率分别为92%~108%和90%~103%,变异系数均小于13%。尿液中3种鹅膏毒肽的准确度为-9.4%~8.0%,重复性和中间精度分别为3.0%~14%和3.5%~18%,当取样量为2.00 mL时,方法的检出限均为0.002 ng/mL;血浆中3种鹅膏毒肽的准确度为-13%~8.0%,重复性和中间精度分别为3.9%~9.7%和5.5%~12%,当取样量为1.00 mL时,方法的检出限均为0.004 ng/mL。该法操作简单、灵敏、准确,已在中毒患者摄入野生蘑菇后138 h的尿液中检出0.0067 ng/mL α-鹅膏毒肽和0.0059 ng/mL β-鹅膏毒肽。该法已成功解决中毒患者尿液和血浆中超痕量鹅膏毒肽的检测难题,对于疑似中毒病人的早诊断、早治疗、降低死亡率都具有非常重要意义,也为今后开展此类毒素毒理作用及机体代谢规律的研究提供了可靠的技术支撑。     

α-氨基酸各官能团对其Co(Ⅱ)配合物可逆氧合性能的影响

选择氧合性能良好的组氨酸(His)-Co(Ⅱ)作为研究对象, 分别掩蔽—NH₂、 取代—O^-和去除—COO^-, 得到短肽、 伪肽和多胺等类组氨酸结构. 采用UV-Vis光谱法研究了α-氨基酸中的3个官能团对其Co(Ⅱ)配合物氧合性能的影响. 对比研究表明: α-氨基酸中—NH₂对其Co(Ⅱ)配合物的吸氧性具有决定作用; —COO^-对其Co(Ⅱ)配合物氧合作用的可逆性起关键作用; 而—O^-对其Co(Ⅱ)配合物的吸氧性影响不大. 在前期研究结果的基础上, 对α-氨基酸-Co(Ⅱ)配合物可逆吸收和释放O₂的机理进行了探讨.     

柳叶五层龙正丁醇提取部分中的3个新酚性成分及其α-葡萄糖苷酶抑制活性

采用多种色谱分离方法从柳叶五层龙(Salacia cochinchinensis Lour)的茎叶中分离得到5个化合物. 通过一维(1D)及二维核磁共振波谱(2D NMR), 包括核磁共振氢谱(¹H NMR)、 核磁共振碳谱(¹³C NMR)、 异核单量子相关(HSQC)、 异核多键相关(HMBC)、 氢氢相关(¹H-¹H COSY)和旋转坐标中的欧沃豪斯增强光谱(ROESY), 以及红外光谱(IR)和电喷雾电离高分辨质谱(ESI-HRMS)等方法, 鉴定其结构分别为Salaciacochinoside A(1), 5'-O-3,4,5-trimethoxybenzoyl-β-D-apiofuranoside(2), 5-methoxy-anticerol A(3), 21α,30-dihydroxy-D∶A-friedooleanan-3-one(4)和21α,26-dihydroxyfriedelan-3-one(5). 化合物1~3为新化合物. α-葡萄糖苷酶抑制活性测试结果显示, 化合物1和3对α-葡萄糖苷酶具有显著的抑制作用, 其IC₅₀值分别为0.32和0.59 μmol/L; 化合物2, 4和5未表现出α-葡萄糖苷酶抑制活性.     

无溶剂、无催化剂条件下α-腺嘌呤阿拉伯糖苷的合成

为了发展有效合成α-腺嘌呤阿拉伯糖苷的方法,以1,2,3,5-四-O-乙酰基-β-D-阿拉伯糖和6-氯嘌呤为原料,在微波辐射和无溶剂、无催化剂条件下反应得到中间体9-α-D-(2',3',5'-三-O-乙酰基)阿拉伯呋喃糖基-6-氯嘌呤,收率85%。 该中间体物在Na₂CO₃催化下脱除乙酰基,然后“一锅”加入饱和的NH₃/CH₃OH溶液氨解,以90%的收率得到α-腺嘌呤阿拉伯糖苷。 关键中间体9-α-D-(2',3',5'-三-O-乙酰基)阿拉伯呋喃糖基-6-氯嘌呤的合成反应规模可以扩大到100 g。 类似地合成α-2-氟腺嘌呤阿拉伯糖苷和α-2-氨基腺嘌呤阿拉伯糖苷。     

赖氨酸C端内切酶/胰蛋白酶顺序酶切在蛋白质组学样本制备中的评估

采用胰蛋白酶(Trypsin)单独酶切与不同酶量的赖氨酸C端内切酶(Lys-C/trypsin)顺序酶切两种方法,对293T细胞全蛋白样本进行酶解消化,系统评估Lys-C/trypsin顺序酶切与Trypsin单一酶切在蛋白质组学样本制备中的差别.实验结果表明,Lys-C/trypsin顺序酶切不仅能显著提高肽段和蛋白质的鉴定数目,同时降低遗漏K酶切位点的数目及比例,而且得到的肽段长度有利于质谱鉴定,蛋白质覆盖率明显提升.通过对酶的用量进行优化对比,最终确定了Lys-C/trypsin顺序酶切时酶的合理用量.本研究结果对提高蛋白质组学样本的制备质量以及蛋白质的序列鉴定覆盖度具有指导意义.     

QuEChERS结合超高效液相色谱-串联质谱法同时测定畜禽肉中44种食源性兴奋剂和6种孕激素

利用QuEChERS结合超高效液相色谱-串联质谱法建立了畜禽肉中44种兴奋剂和6种孕激素的检测技术。样品粉碎均质后加入内标,依次加入水和含0.5%乙酸的乙腈溶液振荡提取后,加入氯化钠和无水硫酸镁脱水离心,上清液采用PSA、C₁₈、中性氧化铝和无水硫酸镁分散固相萃取材料进行净化,净化液经氮气吹干,复溶后用超高效液相色谱-串联质谱仪测定。被测物采用ACQUITY BEH C₁₈(100 mm×2.1 mm, 1.7 μm)色谱柱,以0.1%甲酸-5 mmol/L乙酸铵水溶液和甲醇为流动相分离,在电喷雾正离子模式下,以多反应监测(MRM)方式采集,采用基质匹配标准曲线内标法定量分析。50个被测物包含6类化合物:β₂-激动剂类(19个)、β-阻断剂类(3个)、蛋白同化激素类(11个)、糖皮质激素类(8个)、利尿剂类(3个)、孕激素(6个)。所有被测物在各自的范围内线性关系良好,相关系数>0.99, β₂-激动剂类和β-阻断剂类的线性范围为0.1~20 μg/L,糖皮质激素类的线性范围为0.5~200 μg/L,蛋白同化激素类、孕激素类、利尿剂类的线性范围为0.2~50 μg/L。方法的定量限范围为0.1~0.4 μg/kg。在低、中、高3个浓度水平下的加标回收率试验中,50种目标化合物在鸡肉、猪肉、牛肉、羊肉中的平均回收率范围为50.3%~119.9%,相对标准偏差(RSD, n=6)范围为0.42%~15.1%。采用该法和国标方法(GB/T 21981-2008)同时对市售的9个肉样品(包括3个牛肉、3个猪肉、2个鸡肉、1个鸭肉)进行了比对检测,对检出的氢化可的松、可的松含量采用t检验进行统计学分析,结果表明,两种方法测得的数据没有显著性差异。采用该法测定了12个来自某养殖场的牛肉样品,结果共检出4种食源性兴奋剂,其中氢化可的松的含量范围为3.3~22.6 μg/kg,检出率为100%;可的松的含量范围为1.5~2.1 μg/kg,检出率为67%;雄烯二酮含量范围为0.7~1.2 μg/kg,检出率为17%;睾酮含量范围为0.6~1.5 μg/kg,检出率为42%。该法操作简单,准确灵敏,重复性好,适用于不同种类畜禽肉中食源性兴奋剂和孕激素的检测。     

马鲛鱼抗氧化肽的纳流液相色谱法分离与筛选

在海洋天然产物中,马鲛鱼是一种重要的高活性抗氧化肽生物源,具有极高的加工附加值。由于鱼体组织的复杂性,活性抗氧化肽成分的提取和筛选对样品制备和分离技术提出了挑战。使用不同蛋白酶对鱼体组织进行酶解时,所获得的活性肽结构及功能活性会有显著的差别。为了获得高活性的抗氧化肽,该研究分别考察了风味蛋白酶、胰蛋白酶、酸性蛋白酶、中性蛋白酶、碱性蛋白酶5种蛋白酶的酶解效果。以二苯代苦味肼基自由基(DPPH·)、羟自由基(·OH)清除率和水解度(DH)为指标,筛选最优水解酶。结果表明,胰蛋白酶酶解液清除DPPH·和·OH能力最强,清除率分别达到88.93%±0.82%和53.09%±0.73%。在单因素试验的基础上,以DPPH·清除率为响应值,以加酶量、酶解温度和时间为函数,进行了三因素三水平响应面试验,获得水解度23.66%、DPPH·清除率93.78%以及·OH清除率62.59%的最优制备条件。纳流液相色谱具有低样品量、低溶剂消耗和高效等优势。为筛选出适合于马鲛鱼内脏抗氧化肽分离分析的固定相,该研究使用1∶1000分流比的纳流液相平台,分别使用反相C18柱(15 cm×100 μm, 5 μm, 30 nm)和强阳离子交换柱(15 cm×100 μm, 5 μm, 100 nm)进行分离,收集、冻干并评测了各组分的抗氧化能力。结果表明,强阳离子交换固定相更适合于马鲛鱼内脏抗氧化肽的分离纯化,并筛选出1个强活性抗氧化肽组分。该组分DPPH·清除力的半抑制浓度(IC₅₀)为0.672±0.051 mg/mL,与纯化前相比提高了13.6倍。该研究报道了纳流液相色谱在海洋天然产物源抗氧化肽分离分析中的应用,并证明了其在活性抗氧化肽成分筛选中的有效性和良好的应用前景。     

高效液相色谱-串联质谱法测定肉制品和调味料中7种水产品过敏原

基于高效液相色谱-串联质谱系统建立了食品中水产品过敏原的快速筛查和定量检测方法。样品经蛋白质提取、纯化、胰蛋白酶解后，利用超高效液相色谱-四极杆/静电场轨道阱高分辨质谱（UPLC-Q/Exactive-HRMS）结合ProteinPilot软件，基于母离子和碎片离子谱分析，实现蛋白质和多肽的鉴定。再通过基本局部比对搜索工具（BLAST）与Uniprot数据库对比分析，筛选出南美白虾、大闸蟹、青蟹、金枪鱼、大西洋鲑鱼的7种过敏原蛋白的30个特征肽。利用高效液相色谱-三重四极杆质谱（UPLC-QqQ-MS）系统对特征肽进行验证和多反应监测（MRM）定量研究。结果表明，该方法在5~250 mg/kg范围内线性关系良好，检出限为2~3.5 mg/kg，平均回收率为88.7%~110.2%。该方法重现性好，通量高，可应用于肉制品和调味料中7种过敏原的快速筛查和定量分析。     

桥连双(酮亚胺)和双(二酮亚胺)及其铝配合物的合成与催化活性

通过桥连双β-二酮类化合物与取代苯胺反应, 合成了5个新的桥连双(β-单酮亚胺)化合物(1~5)和2个新的桥连双(β-二酮亚胺)化合物(6,7), 它们与三甲基铝反应, 得到了相应的3个双(β-酮亚胺基)二铝配合物(8~10)和2个双(β-二酮亚胺基)二铝配合物(11,12). 采用核磁共振、 红外光谱和质谱等对这些化合物进行了表征, 通过X射线单晶衍射分析证实了铝配合物的结构, 并考察了这些铝配合物在ε-己内酯开环聚合反应中的催化活性.     

质谱法定量测定高密度脂蛋白结合蛋白的糖基化水平

采用质谱法对4种高密度脂蛋白(HDL)的结合蛋白重组人载脂蛋白血清淀粉样蛋白A(SAA)、 α1-抗胰蛋白酶(A1AT)、 α2-人体血清糖蛋白(A2HSG)和A载脂蛋白C3(Apo C3)从蛋白质含量(蛋白的绝对定量)、 位点特异性糖基化(糖肽的相对定量)及聚糖位点占有率等方面进行了研究. 利用四极杆-飞行时间质谱仪(Q-TOF)测量糖蛋白标样酶解产物的二级质谱碎片离子, 用Byonic软件发现了新的糖基化位点信息, 即增加了原位点处聚糖糖型的种类. 对于A2HSG, 新增了N-糖基化156位点上的4种糖型, N-糖基化176位点上的6种糖型, O-糖基化319位点的4种O-聚糖和O-糖基化346位点上的1种糖型. 对于Apo C3, 只有O-糖基化94一个位点, 在此位点上新增了9种糖型. 同时, 调整了用于定量蛋白的多肽, 使得定量更加准确. 采用三重四极杆串级质谱仪(UPLC-ESI-QQQ)研究了4种结合蛋白中多肽和糖肽的多反应监测(MRM)行为, 并重新计算了每种聚糖的位点占有率, 优化了现有的定量方法.     

Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides

An extensive study was carried out on HSA and non-enzymatically glycated HSA by enzymatic digestion with trypsin and endoproteinase Lys-C, with the aim of identifying specific glycated peptides deriving from enzymatic digestion of glycated HSA. They may be considered, in pectore, as advanced glycation end products/peptides. These compounds, important at a systemic level in diabetic and nephropathic subjects, are produced by enzymatic digestion of in vivo glycated proteins: They are related to the pathological state of patients and have been invoked as responsible for tissue modifications. The digested mixtures obtained by the two enzymes were analyzed by MALDI/MS and LC/ESI/MSn, and clear cut differences were found. First of all, the digestion products of glycated HSA are generally less abundant than those observed in the case of unglycated HSA, accounting for the lower proclivity of the former to enzymatic digestion. MS/MS experiments on doubly charged ions, comparisons with a protein database, and molecular modeling to identify the lysine NH2 groups most exposed to glycation, identified some glycated peptides in digestion mixtures obtained from both types of enzymatic digestion. Residues 233K, 276K, 378K, 545K, and 525K seem to be privileged glycation sites, in agreement with the fractional solvent accessible surface values calculated by molecular modeling.     

盐酸胍/Ⅰ型胶原分散体系的流变性

采用胃蛋白酶降解法从猪皮中提取了胶原蛋白, 用十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)确定为Ⅰ型胶原; 红外及紫外光谱表明胶原分子中存在三螺旋结构. 分别采用小幅振荡剪切法、 恒定剪切速率法及滞后环法研究了盐酸胍浓度及作用时间对Ⅰ型胶原蛋白体系流变性的影响. 研究表明, 随盐酸胍浓度的增大及作用时间的延长, 盐酸胍/胶原分散体系由假塑性流体逐渐接近于牛顿流体. 在所研究的盐酸胍浓度范围(0~6.0 mol/L)内, 盐酸胍/胶原分散体系的触变性类型随盐酸胍浓度的增大发生正触变性-复合触变性-负触变性的转变; 随盐酸胍作用时间的延长(6~48 h), 盐酸胍浓度为1.0 mol/L的胶原分散体系的触变性类型发生复合触变性-负触变性的转变. 本文的研究结果有助于加深对触变性产生机理的认识.     

Strategies in protein sequencing and characterization: Multi-enzyme digestion coupled with alternate CID/ETD tandem mass spectrometry

A strategy based on a simultaneous multi-enzyme digestion coupled with electron transfer dissociation (ETD) and collision-induced dissociation (CID) was developed for protein sequencing and characterization, as a valid alternative platform in ion-trap based proteomics. The effect of different proteolytic procedures using chymotrypsin, trypsin, a combination of both, and Lys-C, was carefully evaluated in terms of number of identified peptides, protein coverage, and score distribution. A systematic comparison between CID and ETD is shown for the analysis of peptides originating from the in-solution digestion of standard caseins. The best results were achieved with a trypsin/chymotrypsin mix combined with CID and ETD operating in alternating mode. A post-database search validation of MS/MS dataset was performed, then, the matched peptides were cross checked by the evaluation of ion scores, rank, number of experimental product ions, and their relative abundances in the MS/MS spectrum. By integrated CID/ETD experiments, high quality-spectra have been obtained, thus allowing a confirmation of spectral information and an increase of accuracy in peptide sequence assignments. Overlapping peptides, produced throughout the proteins, reduce the ambiguity in mapping modifications between natural variants and animal species, and allow the characterization of post translational modifications. The advantages of using the enzymatic mix trypsin/chymotrypsin were confirmed by the nanoLC and CID/ETD tandem mass spectrometry of goat milk proteins, previously separated by two-dimensional gel electrophoresis.     

急性瘦肉精中毒检材的QuEChERS净化-液质联用快速确证方法

目前液相色谱串联质谱法测定动物源性食品中瘦肉精普遍采用酶水解提取、固相萃取净化的方式处理样品,该方法耗时长、分析成本高。 本研究采用酸水解和酶水解两种提取方式结合QuEChERS(Quick,Easy,Cheap,Effective,Rugged,Safe)净化和高效液相色谱串联质谱建立了动物性食品中特布他林、沙丁胺醇、莱克多巴胺和克伦特罗4种β2受体激动剂的快速定性确证和定量检测方法。 采用酶水解提取-QuEChERS净化处理样品,在电喷雾离子源正离子扫描(ESI+)和多反应监测(MRM)模式下,4种瘦肉精在1.0~20.0 μg/L浓度之间呈线性,线性相关系数均大于0.999,检出限和定量限分别为0.1和0.3 μg/kg,猪肉和牛肉样品中4种化合物的回收率为78.5%~112%,相对标准偏差RSD为2.8%~8.9%。 采用酸水解法代替酶水解提取时,尽管对于样品中莱克多巴胺测定结果稍偏低,但样品前处理时间大大缩短。 两种提取方法结合使用对于提高瘦肉精引起的食物中毒应急处置效率具有重要意义。     

First screening method for the simultaneous detection of seven allergens by liquid chromatography mass spectrometry

The development of a multi-method for the detection of seven allergens based on liquid chromatography and triple-quadrupole tandem mass spectrometry in multiple reaction mode is described. It is based on extraction of the allergenic proteins from a food matrix, followed by enzymatic digestion with trypsin. The chosen marker peptides were implemented into one method that is capable of the simultaneous detection of milk, egg, soy, hazelnut, peanut, walnut and almond. This method has been used to detect all seven allergenic commodities from incurred reference bread material, which was baked according to a standard recipe from the baking industry. Detected concentrations ranged from 10 to 1000 μg/g, demonstrating that the mass spectrometric based method is a useful tool for allergen screening.     

Determination of bovine lactoferrin in dairy products by ultra-high performance liquid chromatography–tandem mass spectrometry based on tryptic signature peptides employing an isotope-labeled winged peptide as internal standard

A new and sensitive determination method was developed for bovine lactoferrin in dairy products including infant formulas based on the signature peptide by ultra high-performance liquid chromatography and triple-quadrupole tandem mass spectrometry under the multiple reaction monitoring mode. The simple pretreatment procedures included the addition of a winged peptide containing the isotope-labeled signature peptide as internal standard, followed by an enzymatic digestion with trypsin. The signature peptide was chosen and identified from the tryptic hydrolyzates of bovine lactoferrin by ultra high-performance liquid chromatography and quadrupole-time-of-flight tandem mass spectrometry based on sequence database search. Analytes were separated on an ACQUITY UPLC BEH 300 C18 column and monitored by MS/MS in seven minutes. Quantitative result bias due to matrix effect and tryptic efficiency was corrected through the use of synthetic isotope-labeled standards. The limit of detection and limit of quantification were 0.3 mg/100 g and 1.0 mg/100 g, respectively. Bovine lactoferrin within the concentration range of 10–1000 nmol L⁻¹ showed a strong linear relationship with a linear correlation coefficient (r) of >0.998. The intra- and inter-day precision of the method were RSD < 6.5% and RSD < 7.1%, respectively. Excellent repeatability (RSD < 6.4%) substantially supported the application of this method for the determination of bovine lactoferrin in dairy samples. The present method was successfully validated and applied to determination of bovine lactoferrin in dairy products including infant formulas.     

Comprehensive analysis of glycated human serum albumin tryptic peptides by off-line liquid chromatography followed by MALDI analysis on a time-of-flight/curved field reflectron tandem mass spectrometer

Glycated peptides arising from in vivo digestion of glycated proteins, usually called advanced glycation end (AGE) product peptides, are biologically relevant compounds due to their reactivity towards circulating and tissue proteins. To investigate their structures, in vitro glycation of human serum albumin (HSA) has been performed and followed by enzymatic digestion. Using different MALDI based approaches the digestion products obtained have been compared with those arising from enzymatic digestion of the protein. Results obtained using 2,5-dihydroxybenzoic acid (DHB) indicate this as the most effective matrix, leading to an increase in the coverage of the glycated protein. Off-line microbore liquid chromatography prior to MALDI analysis reveals that 63% of the free amino groups amenable to glycation are modified. In addition, the same approach shows the co-presence of underivatised peptides. This indicates that, regardless of the high glucose concentration employed for HSA incubation, glycation does not go to completion. Tandem mass spectrometric data suggest that the collision induced dissociation of singly charged glycated peptides leads to specific fragmentation pathways related to the condensed glucose molecule. The specific neutral losses derived from the activated glycated peptides can be used as signature for establishing the occurrence of glycation processes.     

Development of a bioreactor based on trypsin immobilized on monolithic support for the on-line digestion and identification of proteins

The preparation and characterization of a new trypsin-based bioreactor is here described for on-line protein digestion and peptide analysis. Trypsin was immobilized on an epoxy-modified silica monolithic support with a single reaction step and the amount of immobilized enzyme was found to be 66.07 mg (+/-11.75 S.D.)/column (n = 6). The bioreactor was coupled through a switching valve to an analytical column for the on-line digestion, peptide separation and identification of test proteins by ESI-MS-MS. The influence of various parameters (flow rate, temperature, buffer pH and molarity, etc.) on enzymatic activity was investigated by an experimental design and the mostly significant factor was found to be the flow rate. The efficacy of the reported on-line bioreactor for tryptic mapping is reported for somatostatin and myoglobin, selected as model compounds. Tryptic peptide maps obtained by on-line digestion of myoglobin were compared to those obtained by traditional off-line digestion. Sequence coverage obtained with the on-line protocol (21 peptides, 75.16% coverage of myoglobin sequence) was found to be comparable to the one obtained with the off-line protocol (18 peptides, 76.47% coverage). Sensitivity for myoglobin digestion and identification was 0.1 mg/ml. The reproducibily of the peptide maps in terms of retention time was from 1.53 to 4.31%, R.S.D.     

Peptic digestion of beta-casein. Time course and fate of possible bioactive peptides

Numerous peptides obtained by enzymatic digestion of food proteins have been reported to exhibit biological activities. In this study, the focus was placed on peptides of beta-casein from bovine milk after a gastro-analogous in vitro digestion with pepsin, a protease with broad specificity. In order to study the time course of the digestion, the process was stopped after specific times and the samples were subjected to HPLC separation followed by matrix-assisted laser desorption/ionization (MALDI) time-of-flight (TOF) and nanoelectrospray (nanoESI) quadrupole time-of-flight (qTOF) mass spectrometry. A combined sequencing approach using de novo interpretation and databases was employed. Overall, 100% of the beta-casein sequence was covered by identifying 125 peptides of 4-84 residues in length, including 3 phosphorylated species. The results show that the peptic hydrolysis starts at the C-terminus of the protein. The release of known bioactive peptides from beta-casein following the peptic digestion under simulated gastric conditions is unlikely with a few exceptions. Furthermore, an amino acid variation was found, providing evidence for the existence of an additional genetic variant of beta-casein.